Related Experiment Videos
Matrix metalloproteinase-12 is expressed in phagocytotic macrophages in active multiple sclerosis lesions
Catharina M P Vos1, Elise S van Haastert, Corline J A de Groot
1Department of Pathology, Vrije Universiteit Medical Center, De Boelelaan 1117, 1007 MB, Amsterdam, The Netherlands. cmp.vos@vumc.nl
Abstract:
Matrix metalloproteinases (MMPs) are proteases involved in extracellular matrix (ECM) remodeling, leukocyte infiltration into lesions and myelin degradation in the central nervous system (CNS) disease multiple sclerosis (MS). We have investigated whether MMP-12 (macrophage metalloelastase) is expressed in MS lesions at various stages. In control patient tissue and (p)reactive MS lesions, only occasional microglial and astrocyte staining was detected. In contrast, in active demyelinating lesions, phagocytic macrophages were MMP-12 positive. A lower proportion of phagocytes was positive for MMP-12 in chronic active demyelinating lesions and inactive lesions. This suggests a role for MMP-12 during demyelination in MS.
Insights
Matrix metalloproteinases (MMPs), specifically MMP-12, are linked to myelin degradation in multiple sclerosis (MS). This study found MMP-12 expressed in active MS lesions, suggesting its role in demyelination.
Area of Science:
- Neuroimmunology
- Molecular Biology
- Pathology
Background:
- Matrix metalloproteinases (MMPs) are enzymes implicated in extracellular matrix (ECM) remodeling.
- MMPs play roles in leukocyte infiltration and myelin degradation in central nervous system (CNS) diseases.
- Multiple sclerosis (MS) is a CNS disease characterized by demyelination and inflammation.
Purpose of the Study:
- To investigate the expression of matrix metalloproteinase-12 (MMP-12), also known as macrophage metalloelastase, in multiple sclerosis (MS) lesions.
- To determine the stage-specific localization of MMP-12 within MS lesions.
Main Methods:
- Immunohistochemical analysis of human brain tissue from control patients and individuals with MS.
- Examination of MS lesions at various stages: control, (p)reactive, active demyelinating, chronic active demyelinating, and inactive.
Main Results:
- MMP-12 expression was minimal in control and (p)reactive MS lesions, primarily detected in microglia and astrocytes.
- In active demyelinating MS lesions, phagocytic macrophages showed significant MMP-12 positivity.
- MMP-12 positivity in phagocytes was reduced in chronic active and inactive MS lesions.
Conclusions:
- MMP-12 is expressed by macrophages within active demyelinating lesions in multiple sclerosis.
- The findings suggest a potential role for MMP-12 in the process of demyelination during MS pathogenesis.